{"id":1118606,"date":"2023-10-16T06:42:13","date_gmt":"2023-10-16T10:42:13","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/unrealized-targets-in-the-discovery-of-antibiotics-for-gram-negative-nature-com\/"},"modified":"2023-10-16T06:42:13","modified_gmt":"2023-10-16T10:42:13","slug":"unrealized-targets-in-the-discovery-of-antibiotics-for-gram-negative-nature-com","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/transhuman-news-blog\/human-genetics\/unrealized-targets-in-the-discovery-of-antibiotics-for-gram-negative-nature-com\/","title":{"rendered":"Unrealized targets in the discovery of antibiotics for Gram-negative … – Nature.com"},"content":{"rendered":"

Butler, M. S. et al. Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed. Antimicrob. Agents Chemother. 66, e0199121 (2022). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Martnez-Garca, L., Gonzlez-Alba, J. M., Baquero, F., Cantn, R. & Galn, J. C. Ceftazidime is the key diversification and selection driver of VIM-type carbapenemases. mBio 9, e02109e02117 (2018). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Baquero, F. et al. Allogenous selection of mutational collateral resistance: old drugs select for new resistance within antibiotic families. Front. Microbiol. 12, 757833 (2021). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Rajer, F., Allander, L., Karlsson, P. A. & Sandegren, L. Evolutionary trajectories toward high-level -lactam\/-lactamase inhibitor resistance in the presence of multiple -lactamases. Antimicrob. Agents Chemother. 66, e0029022 (2022). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Poirel, L., Sadek, M., Kusaksizoglu, A. & Nordmann, P. Co-resistance to ceftazidimeavibactam and cefiderocol in clinical isolates producing KPC variants. Eur. J. Clin. Microbiol. Infect. Dis. 41, 677680 (2022). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Silver, L. L. Challenges of antibacterial discovery. Clin. Microbiol. Rev. 24, 71109 (2011). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Baker, S. J., Payne, D. J., Rappuoli, R. & De Gregorio, E. Technologies to address antimicrobial resistance. Proc. Natl Acad. Sci. USA 115, 1288712895 (2018). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 2940 (2007). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I. & Miller, A. A. ESKAPEing the labyrinth of antibacterial discovery. Nat. Rev. Drug Discov. 14, 529542 (2015). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Brotz-Oesterhelt, H. & Sass, P. Postgenomic strategies in antibacterial drug discovery. Future Microbiol. 5, 15531579 (2010). <\/p>\n

Article PubMed Google Scholar <\/p>\n

Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371387 (2013). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Muoz, K. A. & Hergenrother, P. J. Facilitating compound entry as a means to discover antibiotics for Gram-negative bacteria. Acc. Chem. Res. 54, 13221333 (2021). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Zhao, S. et al. Defining new chemical space for drug penetration into Gram-negative bacteria. Nat. Chem. Biol. 16, 12931302 (2020). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Sadybekov, A. V. & Katritch, V. Computational approaches streamlining drug discovery. Nature 616, 673685 (2023). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Lluka, T. & Stokes, J. M. Antibiotic discovery in the artificial intelligence era. Ann. NY Acad. Sci. 1519, 7493 (2023). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224229 (2019). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Mobegi, F. M. et al. From microbial gene essentiality to novel antimicrobial drug targets. BMC Genomics 15, 958 (2014). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Agarwal, P. & Searls, D. B. Can literature analysis identify innovation drivers in drug discovery? Nat. Rev. Drug Discov. 8, 865 (2009). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Lange, R. P., Locher, H. H., Wyss, P. C. & Then, R. L. The targets of currently used antibacterial agents: lessons for drug discovery. Curr. Pharm. Des. 13, 31403154 (2007). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Theuretzbacher, U. & Piddock, L. J. V. Non-traditional antibacterial therapeutic options and challenges. Cell Host Microbe 26, 6172 (2019). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Frearson, J. A., Wyatt, P. G., Gilbert, I. H. & Fairlamb, A. H. Target assessment for antiparasitic drug discovery. Trends Parasitol. 23, 589595 (2007). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Streker, K. et al. In vitro and in vivo validation of ligA and tarI as essential targets in Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 44704474 (2008). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Rancati, G., Moffat, J., Typas, A. & Pavelka, N. Emerging and evolving concepts in gene essentiality. Nat. Rev. Genet. 19, 3449 (2018). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Bosch-Guiteras, N. & van Leeuwen, J. Exploring conditional gene essentiality through systems genetics approaches in yeast. Curr. Opin. Genet. Dev. 76, 101963 (2022). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Zhang, Z. & Ren, Q. Why are essential genes essential? the essentiality of Saccharomyces genes. Microb. Cell 2, 280287 (2015). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Chessher, A. Evaluating the suitability of essential genes as targets for antibiotic screening assays using proteomics. Protein Cell 3, 57 (2012). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Editorial. Putting gene essentiality into context. Nat. Rev. Genet. 19, 1 (2017). <\/p>\n

Google Scholar <\/p>\n

Chaudhary, A. S., Chen, W., Jin, J., Tai, P. C. & Wang, B. SecA: a potential antimicrobial target. Future Med. Chem. 7, 9891007 (2015). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Emmerich, C. H. et al. Improving target assessment in biomedical research: the GOT-IT recommendations. Nat. Rev. Drug Discov. 20, 6481 (2021). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Murima, P., McKinney, J. D. & Pethe, K. Targeting bacterial central metabolism for drug development. Chem. Biol. 21, 14231432 (2014). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Hedstrom, L. The bare essentials of antibiotic target validation. ACS Infect. Dis. 3, 24 (2017). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Hogan, A. M. & Cardona, S. T. Gradients in gene essentiality reshape antibacterial research. FEMS Microbiol. Rev. 46, fuac005 (2022). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Bergmiller, T., Ackermann, M. & Silander, O. K. Patterns of evolutionary conservation of essential genes correlate with their compensability. PLoS Genet. 8, e1002803 (2012). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Dunman, P. M. & Tomaras, A. P. Translational deficiencies in antibacterial discovery and new screening paradigms. Curr. Opin. Microbiol. 27, 108113 (2015). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Rosconi, F. et al. A bacterial pan-genome makes gene essentiality strain-dependent and evolvable. Nat. Microbiol. 7, 15801592 (2022). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Kaur, H., Kalia, M. & Taneja, N. Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis. Microb. Pathog. 152, 104608 (2021). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Uddin, R., Masood, F., Azam, S. S. & Wadood, A. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis. Microb. Pathog. 128, 2835 (2019). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Ramos, P. I. P. et al. An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets. Sci. Rep. 8, 10755 (2018). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Rafiq, H. et al. A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumoniae strain PittNDM01. Microb. Pathog. 146, 104245 (2020). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Uddin, R. & Jamil, F. Prioritization of potential drug targets against P. aeruginosa by core proteomic analysis using computational subtractive genomics and proteinprotein interaction network. Comput. Biol. Chem. 74, 115122 (2018). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Nazarshodeh, E., Marashi, S. A. & Gharaghani, S. Structural systems pharmacology: a framework for integrating metabolic network and structure-based virtual screening for drug discovery against bacteria. PLoS ONE 16, e0261267 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Bakheet, T. M. & Doig, A. J. Properties and identification of antibiotic drug targets. BMC Bioinformatics 11, 195 (2010). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Bosch, B. et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell 184, 45794592.e24 (2021). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Hawkins, J. S. et al. Mismatch-CRISPRi reveals the co-varying expressionfitness relationships of essential genes in Escherichia coli and Bacillus subtilis. Cell Syst. 11, 523535.e9 (2020). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Luo, H., Gao, F. & Lin, Y. Evolutionary conservation analysis between the essential and nonessential genes in bacterial genomes. Sci. Rep. 5, 13210 (2015). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Arun, P. V. P. S. et al. Identification and functional analysis of essential, conserved, housekeeping and duplicated genes. FEBS Lett. 590, 14281437 (2016). <\/p>\n

Article CAS PubMed Google Scholar <\/p>\n

Du, W. et al. Two active forms of UDP-N-acetylglucosamine enolpyruvyl transferase in Gram-positive bacteria. J. Bacteriol. 182, 41464152 (2000). <\/p>\n

Article CAS PubMed PubMed Central Google Scholar <\/p>\n

Naz, S., Ngo, T., Farooq, U. & Abagyan, R. Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens. PeerJ 5, e3765e3765 (2017). <\/p>\n

Article PubMed PubMed Central Google Scholar <\/p>\n

Klahn, P. & Bronstrup, M. New structural templates for clinically validated and novel targets in antimicrobial drug research and development. Curr. Top. Microbiol. Immunol. 398, 365417 (2016). <\/p>\n

CAS PubMed Google Scholar <\/p>\n

Miranda, R. R., Parthasarathy, A. & Hudson, A. O. Exploration of chemical biology approaches to facilitate the discovery and development of novel antibiotics. Front. Trop. Dis. 3, 845469 (2022). <\/p>\n

Article Google Scholar <\/p>\n

<\/p>\n

See the original post:
\nUnrealized targets in the discovery of antibiotics for Gram-negative ... - Nature.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Butler, M. S. et al. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-1118606","post","type-post","status-publish","format-standard","hentry","category-human-genetics"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1118606"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1118606"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1118606\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1118606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1118606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1118606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}